Prot #VX16-445-001: A Phase 1/2 Study of VX-445 in Healthy Subjects and Subjects with Cystic Fibrosis

Project: Research project

Project Details

StatusFinished
Effective start/end date7/3/177/3/20

Funding

  • Covance Inc. (Prot #VX16-445-001)
  • Vertex Pharmaceuticals Incorporated (Prot #VX16-445-001)